227 related articles for article (PubMed ID: 23887604)
21. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial.
Cook NR; Lee IM; Zhang SM; Moorthy MV; Buring JE
Ann Intern Med; 2013 Jul; 159(2):77-85. PubMed ID: 23856681
[TBL] [Abstract][Full Text] [Related]
22. The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study.
Huang WK; Chiou MJ; Yu KH; Lin YC; Yang TS; Chen JS; Kuo CF; See LC
Aliment Pharmacol Ther; 2013 Aug; 38(4):432-9. PubMed ID: 23799975
[TBL] [Abstract][Full Text] [Related]
23. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
24. A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.
Jacobs EJ; Thun MJ; Bain EB; Rodriguez C; Henley SJ; Calle EE
J Natl Cancer Inst; 2007 Apr; 99(8):608-15. PubMed ID: 17440162
[TBL] [Abstract][Full Text] [Related]
25. Effects of aspirin on small-cell lung cancer mortality and metastatic presentation.
Maddison P
Lung Cancer; 2017 Apr; 106():67-69. PubMed ID: 28285696
[TBL] [Abstract][Full Text] [Related]
26. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
[TBL] [Abstract][Full Text] [Related]
27. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
Algra AM; Rothwell PM
Lancet Oncol; 2012 May; 13(5):518-27. PubMed ID: 22440112
[TBL] [Abstract][Full Text] [Related]
28. Effect of aspirin and NSAIDs on risk and survival from colorectal cancer.
Din FV; Theodoratou E; Farrington SM; Tenesa A; Barnetson RA; Cetnarskyj R; Stark L; Porteous ME; Campbell H; Dunlop MG
Gut; 2010 Dec; 59(12):1670-9. PubMed ID: 20844293
[TBL] [Abstract][Full Text] [Related]
29. Aspirin and cancer risk: an update to 2001.
Bosetti C; Gallus S; La Vecchia C
Eur J Cancer Prev; 2002 Dec; 11(6):535-42. PubMed ID: 12457105
[TBL] [Abstract][Full Text] [Related]
30. The Protective Effect of Low-Dose Aspirin against Colorectal Cancer Is Unlikely Explained by Selection Bias: Results from Three Different Study Designs in Clinical Practice.
Cea Soriano L; Soriano-Gabarró M; García Rodríguez LA
PLoS One; 2016; 11(7):e0159179. PubMed ID: 27428004
[TBL] [Abstract][Full Text] [Related]
31. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
32. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
Joharatnam-Hogan N; Cafferty F; Hubner R; Swinson D; Sothi S; Gupta K; Falk S; Patel K; Warner N; Kunene V; Rowley S; Khabra K; Underwood T; Jankowski J; Bridgewater J; Crossley A; Henson V; Berkman L; Gilbert D; Kynaston H; Ring A; Cameron D; Din F; Graham J; Iveson T; Adams R; Thomas A; Wilson R; Pramesh CS; Langley R;
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):854-862. PubMed ID: 31477558
[TBL] [Abstract][Full Text] [Related]
33. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
García-Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
[TBL] [Abstract][Full Text] [Related]
34. Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study.
Skriver C; Dehlendorff C; Borre M; Brasso K; Sørensen HT; Hallas J; Larsen SB; Tjønneland A; Friis S
Cancer Causes Control; 2016 Sep; 27(9):1067-79. PubMed ID: 27503490
[TBL] [Abstract][Full Text] [Related]
35. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
36. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
[TBL] [Abstract][Full Text] [Related]
37. Aspirin and prostate cancer prevention.
Bosetti C; Rosato V; Gallus S; La Vecchia C
Recent Results Cancer Res; 2014; 202():93-100. PubMed ID: 24531782
[TBL] [Abstract][Full Text] [Related]
38. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Bradley MC; Black A; Freedman AN; Barron TI
Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
[TBL] [Abstract][Full Text] [Related]
39. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort.
Dhillon PK; Kenfield SA; Stampfer MJ; Giovannucci EL; Chan JM
Cancer Prev Res (Phila); 2012 Oct; 5(10):1223-8. PubMed ID: 22961777
[TBL] [Abstract][Full Text] [Related]
40. Risk of lower gastrointestinal bleeding and colorectal neoplasms following initiation of low-dose aspirin: a Danish population-based cohort study.
Troelsen FS; Farkas DK; Erichsen R; Sørensen HT
BMJ Open Gastroenterol; 2020 Jul; 7(1):. PubMed ID: 32719046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
